Vineet R. Jindal - Net Worth and Insider Trading
Vineet R. Jindal Net Worth
The estimated net worth of Vineet R. Jindal is at least $8,300 dollars as of 2024-06-05. Vineet R. Jindal is the CFO of Reneo Pharmaceuticals Inc and owns about 5,000 shares of Reneo Pharmaceuticals Inc (RPHM) stock worth over $8,300. Details can be seen in Vineet R. Jindal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vineet R. Jindal has not made any transactions after 2021-08-25 and currently still holds the listed stock(s).
Transaction Summary of Vineet R. Jindal
Vineet R. Jindal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vineet R. Jindal owns 1 companies in total, including Reneo Pharmaceuticals Inc (RPHM) .
Click here to see the complete history of Vineet R. Jindal’s form 4 insider trades.
Insider Ownership Summary of Vineet R. Jindal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPHM | Reneo Pharmaceuticals Inc | 2021-08-25 | Chief Financial Officer |
Vineet R. Jindal Latest Holdings Summary
Vineet R. Jindal currently owns a total of 1 stock. Vineet R. Jindal owns 5,000 shares of Reneo Pharmaceuticals Inc (RPHM) as of August 25, 2021, with a value of $8,300.
Latest Holdings of Vineet R. Jindal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPHM | Reneo Pharmaceuticals Inc | 2021-08-25 | 5,000 | 1.66 | 8,300 |
Holding Weightings of Vineet R. Jindal
Vineet R. Jindal Form 4 Trading Tracker
According to the SEC Form 4 filings, Vineet R. Jindal has made a total of 1 transactions in Reneo Pharmaceuticals Inc (RPHM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Reneo Pharmaceuticals Inc is the acquisition of 5,000 shares on August 25, 2021, which cost Vineet R. Jindal around $37,200.
Insider Trading History of Vineet R. Jindal
- 1
Vineet R. Jindal Trading Performance
GuruFocus tracks the stock performance after each of Vineet R. Jindal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vineet R. Jindal is 9.66%. GuruFocus also compares Vineet R. Jindal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vineet R. Jindal within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vineet R. Jindal's insider trading performs compared to the benchmark.
Performance of Vineet R. Jindal
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.73 | | | | | |
| Relative Return to S&P 500(%) | 23.64 | | | | | |
Vineet R. Jindal Ownership Network
Vineet R. Jindal Owned Company Details
What does Reneo Pharmaceuticals Inc do?
Who are the key executives at Reneo Pharmaceuticals Inc?
Vineet R. Jindal is the Chief Financial Officer of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .
Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary
Over the past 18 months, Vineet R. Jindal made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 414,281 shares made by Braden Michael Leonard , a net purchase of 125,000 shares made by Niall O'donnell , and a net sale of 100,000 shares made by Novo Holdings A/s .
In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 414,281 shares, with a net purchase of 414,281 shares. During the past 18 months, 115,625 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 539,281 shares were bought by its insiders, resulting in a net purchase of 423,656 shares.
Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reneo Pharmaceuticals Inc Insider Transactions
Vineet R. Jindal Mailing Address
Above is the net worth, insider trading, and ownership report for Vineet R. Jindal. You might contact Vineet R. Jindal via mailing address: C/o Reneo Pharmaceuticals, Inc., 12230 El Camino Real, Suite 230, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
